PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-Mar-2023 Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development Modus Therapeutics
30-Mar-2023 ProBioGen Delivers Strong 2022 Performance, Investing for Growth in 2023 B3C newswire
30-Mar-2023 Biotest AG: Biotest achieves important milestone in phase III trial in acquired fibrinogen deficiency Biotest AG
30-Mar-2023 RHÖN-KLINIKUM AG looks back on successful financial year 2022 RHÖN-KLINIKUM Aktiengesellschaft
30-Mar-2023 Medios AG expects continued growth after record year in 2022 and plans further increase in profit margin Medios AG
30-Mar-2023 ​​​​​Eckert & Ziegler: Successful fiscal year 2022 Eckert & Ziegler Strahlen- und Medizintechnik AG
30-Mar-2023 PAION AG reports on fiscal year 2022 PAION AG
30-Mar-2023 Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX™) with China Medical System Holdings Cosmo Pharmaceuticals N.V.
30-Mar-2023 STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR STRATEC SE
29-Mar-2023 Medacta publishes 2023 Annual General Meeting invitation Medacta Group SA
29-Mar-2023 Cantourage Group SE: Most successful product launch – Canadian “Gelato #33” cannabis strain available for the first time in Germany Cantourage Group SE
29-Mar-2023 Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas Mainz BioMed N.V.
29-Mar-2023 Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH) Lonza Group AG
28-Mar-2023 CureVac Announces Voting Results of Extraordinary General Meeting CureVac
28-Mar-2023 Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards B3C newswire
28-Mar-2023 TEZSPIRE▼(TEZEPELUMAB) TO BE RECOMMENDED BY NICE AS AN ADD-ON TREATMENT FOR SEVERE UNCONTROLLED ASTHMA AstraZeneca
28-Mar-2023 MMIP chair responds to Life Sciences Innovative Manufacturing Fund grants announcement ABPI
28-Mar-2023 AlzeCure presents new data on its preventive treatment Alzstatin at the Alzheimer's conference AD/PD 2023 AlzeCure
28-Mar-2023 MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology B3C newswire
28-Mar-2023 Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry Newron Pharmaceuticals S.p.A.